Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Bladder Cancer treatment details. Chemotherapy. University Hospital Del Mar, Barcelona, Spain

Survival: 6.9 months
Toxicity Grade: 5
Treatments: Chemotherapy
Country: Spain
City/State/Province: Barcelona
Hospital: University Hospital Del Mar
Journal: Link
Date: 9/2009

This phase III study involved 253 patients with a type of bladder cancer called transitional cell carcinoma of the urothelial tract. Patients had received prior platinum-containing chemotherapy. The median patient age was not given, but 46.6% of the patients were at least 65 years old.

Patients in this study were treated with the chemotherapy agent vinflunine.

There was one treatment-related death due to pancytopenia (decrease in both red and white blood cells). Grade 3-4 neutropenia, fatigue, anemia, and constipation were also reported.

The reported median overall survival was 6.9 months.

This study was supported by the pharmaceutical company Pierre Fabre, makers of vinflunine.

Correspondence: Dr. Joaquim Bellmunt; email:

E-mail to a Friend Email Physician More Information